Cargando…
Single‐cell RNA‐seq analysis reveals the platinum resistance gene COX7B and the surrogate marker CD63
Cancers acquire resistance to systemic treatment with platinum‐based chemotherapy (eg, cisplatin [CDDP]) as a result of a dynamic intratumoral heterogeneity (ITH) and clonal repopulation. However, little is known about the influence of chemotherapy on ITH at the single‐cell level. Here, mapping the...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308066/ https://www.ncbi.nlm.nih.gov/pubmed/30367559 http://dx.doi.org/10.1002/cam4.1828 |
_version_ | 1783383115556716544 |
---|---|
author | Tanaka, Nobuyuki Katayama, Shintaro Reddy, Aparna Nishimura, Kaneyasu Niwa, Naoya Hongo, Hiroshi Ogihara, Koichiro Kosaka, Takeo Mizuno, Ryuichi Kikuchi, Eiji Mikami, Shuji Miyakawa, Ayako Arenas, Ernest Kere, Juha Oya, Mototsugu Uhlén, Per |
author_facet | Tanaka, Nobuyuki Katayama, Shintaro Reddy, Aparna Nishimura, Kaneyasu Niwa, Naoya Hongo, Hiroshi Ogihara, Koichiro Kosaka, Takeo Mizuno, Ryuichi Kikuchi, Eiji Mikami, Shuji Miyakawa, Ayako Arenas, Ernest Kere, Juha Oya, Mototsugu Uhlén, Per |
author_sort | Tanaka, Nobuyuki |
collection | PubMed |
description | Cancers acquire resistance to systemic treatment with platinum‐based chemotherapy (eg, cisplatin [CDDP]) as a result of a dynamic intratumoral heterogeneity (ITH) and clonal repopulation. However, little is known about the influence of chemotherapy on ITH at the single‐cell level. Here, mapping the transcriptome of cancers treated with CDDP by scRNA‐seq, we uncovered a novel gene, COX7B, associated with platinum‐resistance, and surrogate marker, CD63. Knockdown of COX7B in cancer cells decreased the sensitivity of CDDP whereas overexpression recovered the sensitivity of CDDP. Low COX7B levels correlated with higher mortality rates in patients with various types of cancer and were significantly associated with poor response to chemotherapy in urinary bladder cancer. Tumor samples from patients, who underwent CDDP therapy, showed decreased COX7B protein levels after the treatment. Analyzing scRNA‐seq data from platinum‐naïve cancer cells demonstrated a low‐COX7B subclone that could be sorted out from bulk cancer cells by assaying CD63. This low‐COX7B subclone behaved as cells with acquired platinum‐resistance when challenged to CDDP. Our results offer a new transcriptome landscape of platinum‐resistance that provides valuable insights into chemosensitivity and drug resistance in cancers, and we identify a novel platinum resistance gene, COX7B, and a surrogate marker, CD63. |
format | Online Article Text |
id | pubmed-6308066 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-63080662019-01-03 Single‐cell RNA‐seq analysis reveals the platinum resistance gene COX7B and the surrogate marker CD63 Tanaka, Nobuyuki Katayama, Shintaro Reddy, Aparna Nishimura, Kaneyasu Niwa, Naoya Hongo, Hiroshi Ogihara, Koichiro Kosaka, Takeo Mizuno, Ryuichi Kikuchi, Eiji Mikami, Shuji Miyakawa, Ayako Arenas, Ernest Kere, Juha Oya, Mototsugu Uhlén, Per Cancer Med Cancer Biology Cancers acquire resistance to systemic treatment with platinum‐based chemotherapy (eg, cisplatin [CDDP]) as a result of a dynamic intratumoral heterogeneity (ITH) and clonal repopulation. However, little is known about the influence of chemotherapy on ITH at the single‐cell level. Here, mapping the transcriptome of cancers treated with CDDP by scRNA‐seq, we uncovered a novel gene, COX7B, associated with platinum‐resistance, and surrogate marker, CD63. Knockdown of COX7B in cancer cells decreased the sensitivity of CDDP whereas overexpression recovered the sensitivity of CDDP. Low COX7B levels correlated with higher mortality rates in patients with various types of cancer and were significantly associated with poor response to chemotherapy in urinary bladder cancer. Tumor samples from patients, who underwent CDDP therapy, showed decreased COX7B protein levels after the treatment. Analyzing scRNA‐seq data from platinum‐naïve cancer cells demonstrated a low‐COX7B subclone that could be sorted out from bulk cancer cells by assaying CD63. This low‐COX7B subclone behaved as cells with acquired platinum‐resistance when challenged to CDDP. Our results offer a new transcriptome landscape of platinum‐resistance that provides valuable insights into chemosensitivity and drug resistance in cancers, and we identify a novel platinum resistance gene, COX7B, and a surrogate marker, CD63. John Wiley and Sons Inc. 2018-10-26 /pmc/articles/PMC6308066/ /pubmed/30367559 http://dx.doi.org/10.1002/cam4.1828 Text en © 2018 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Cancer Biology Tanaka, Nobuyuki Katayama, Shintaro Reddy, Aparna Nishimura, Kaneyasu Niwa, Naoya Hongo, Hiroshi Ogihara, Koichiro Kosaka, Takeo Mizuno, Ryuichi Kikuchi, Eiji Mikami, Shuji Miyakawa, Ayako Arenas, Ernest Kere, Juha Oya, Mototsugu Uhlén, Per Single‐cell RNA‐seq analysis reveals the platinum resistance gene COX7B and the surrogate marker CD63 |
title | Single‐cell RNA‐seq analysis reveals the platinum resistance gene COX7B and the surrogate marker CD63 |
title_full | Single‐cell RNA‐seq analysis reveals the platinum resistance gene COX7B and the surrogate marker CD63 |
title_fullStr | Single‐cell RNA‐seq analysis reveals the platinum resistance gene COX7B and the surrogate marker CD63 |
title_full_unstemmed | Single‐cell RNA‐seq analysis reveals the platinum resistance gene COX7B and the surrogate marker CD63 |
title_short | Single‐cell RNA‐seq analysis reveals the platinum resistance gene COX7B and the surrogate marker CD63 |
title_sort | single‐cell rna‐seq analysis reveals the platinum resistance gene cox7b and the surrogate marker cd63 |
topic | Cancer Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308066/ https://www.ncbi.nlm.nih.gov/pubmed/30367559 http://dx.doi.org/10.1002/cam4.1828 |
work_keys_str_mv | AT tanakanobuyuki singlecellrnaseqanalysisrevealstheplatinumresistancegenecox7bandthesurrogatemarkercd63 AT katayamashintaro singlecellrnaseqanalysisrevealstheplatinumresistancegenecox7bandthesurrogatemarkercd63 AT reddyaparna singlecellrnaseqanalysisrevealstheplatinumresistancegenecox7bandthesurrogatemarkercd63 AT nishimurakaneyasu singlecellrnaseqanalysisrevealstheplatinumresistancegenecox7bandthesurrogatemarkercd63 AT niwanaoya singlecellrnaseqanalysisrevealstheplatinumresistancegenecox7bandthesurrogatemarkercd63 AT hongohiroshi singlecellrnaseqanalysisrevealstheplatinumresistancegenecox7bandthesurrogatemarkercd63 AT ogiharakoichiro singlecellrnaseqanalysisrevealstheplatinumresistancegenecox7bandthesurrogatemarkercd63 AT kosakatakeo singlecellrnaseqanalysisrevealstheplatinumresistancegenecox7bandthesurrogatemarkercd63 AT mizunoryuichi singlecellrnaseqanalysisrevealstheplatinumresistancegenecox7bandthesurrogatemarkercd63 AT kikuchieiji singlecellrnaseqanalysisrevealstheplatinumresistancegenecox7bandthesurrogatemarkercd63 AT mikamishuji singlecellrnaseqanalysisrevealstheplatinumresistancegenecox7bandthesurrogatemarkercd63 AT miyakawaayako singlecellrnaseqanalysisrevealstheplatinumresistancegenecox7bandthesurrogatemarkercd63 AT arenasernest singlecellrnaseqanalysisrevealstheplatinumresistancegenecox7bandthesurrogatemarkercd63 AT kerejuha singlecellrnaseqanalysisrevealstheplatinumresistancegenecox7bandthesurrogatemarkercd63 AT oyamototsugu singlecellrnaseqanalysisrevealstheplatinumresistancegenecox7bandthesurrogatemarkercd63 AT uhlenper singlecellrnaseqanalysisrevealstheplatinumresistancegenecox7bandthesurrogatemarkercd63 |